BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 37711895)

  • 1. AIB1/SRC-3/NCOA3 function in estrogen receptor alpha positive breast cancer.
    Kiliti AJ; Sharif GM; Martin MB; Wellstein A; Riegel AT
    Front Endocrinol (Lausanne); 2023; 14():1250218. PubMed ID: 37711895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AIB1 sequestration by androgen receptor inhibits estrogen-dependent cyclin D1 expression in breast cancer cells.
    De Amicis F; Chiodo C; Morelli C; Casaburi I; Marsico S; Bruno R; Sisci D; Andò S; Lanzino M
    BMC Cancer; 2019 Nov; 19(1):1038. PubMed ID: 31684907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AIB1:ERα transcriptional activity is selectively enhanced in aromatase inhibitor-resistant breast cancer cells.
    O'Hara J; Vareslija D; McBryan J; Bane F; Tibbitts P; Byrne C; Conroy RM; Hao Y; Gaora PÓ; Hill AD; McIlroy M; Young LS
    Clin Cancer Res; 2012 Jun; 18(12):3305-15. PubMed ID: 22550166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amplified in Breast Cancer Regulates Transcription and Translation in Breast Cancer Cells.
    Ochnik AM; Peterson MS; Avdulov SV; Oh AS; Bitterman PB; Yee D
    Neoplasia; 2016 Feb; 18(2):100-10. PubMed ID: 26936396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered AIB1 or AIB1Δ3 expression impacts ERα effects on mammary gland stromal and epithelial content.
    Nakles RE; Shiffert MT; Díaz-Cruz ES; Cabrera MC; Alotaiby M; Miermont AM; Riegel AT; Furth PA
    Mol Endocrinol; 2011 Apr; 25(4):549-63. PubMed ID: 21292825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic relevance of AIB1 (NCoA3) amplification and overexpression in breast cancer.
    Burandt E; Jens G; Holst F; Jänicke F; Müller V; Quaas A; Choschzick M; Wilczak W; Terracciano L; Simon R; Sauter G; Lebeau A
    Breast Cancer Res Treat; 2013 Feb; 137(3):745-53. PubMed ID: 23322234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CK1delta modulates the transcriptional activity of ERalpha via AIB1 in an estrogen-dependent manner and regulates ERalpha-AIB1 interactions.
    Giamas G; Castellano L; Feng Q; Knippschild U; Jacob J; Thomas RS; Coombes RC; Smith CL; Jiao LR; Stebbing J
    Nucleic Acids Res; 2009 May; 37(9):3110-23. PubMed ID: 19339517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen-related receptor alpha expression and function is associated with the transcriptional coregulator AIB1 in breast carcinoma.
    Heck S; Rom J; Thewes V; Becker N; Blume B; Sinn HP; Deuschle U; Sohn C; Schneeweiss A; Lichter P
    Cancer Res; 2009 Jun; 69(12):5186-93. PubMed ID: 19491275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NCOA3 is a selective co-activator of estrogen receptor α-mediated transactivation of PLAC1 in MCF-7 breast cancer cells.
    Wagner M; Koslowski M; Paret C; Schmidt M; Türeci O; Sahin U
    BMC Cancer; 2013 Dec; 13():570. PubMed ID: 24304549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of an N-terminally truncated isoform of the nuclear receptor coactivator amplified in breast cancer 1 leads to altered proliferation of mammary epithelial cells in transgenic mice.
    Tilli MT; Reiter R; Oh AS; Henke RT; McDonnell K; Gallicano GI; Furth PA; Riegel AT
    Mol Endocrinol; 2005 Mar; 19(3):644-56. PubMed ID: 15550471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of steroid receptor coactivator AIB1 with estrogen receptor-alpha in breast cancer cells.
    Azorsa DO; Cunliffe HE; Meltzer PS
    Breast Cancer Res Treat; 2001 Nov; 70(2):89-101. PubMed ID: 11768608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosine phosphorylation of the nuclear receptor coactivator AIB1/SRC-3 is enhanced by Abl kinase and is required for its activity in cancer cells.
    Oh AS; Lahusen JT; Chien CD; Fereshteh MP; Zhang X; Dakshanamurthy S; Xu J; Kagan BL; Wellstein A; Riegel AT
    Mol Cell Biol; 2008 Nov; 28(21):6580-93. PubMed ID: 18765637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of target genes in breast cancer cells directly regulated by the SRC-3/AIB1 coactivator.
    Labhart P; Karmakar S; Salicru EM; Egan BS; Alexiadis V; O'Malley BW; Smith CL
    Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1339-44. PubMed ID: 15677324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the nuclear receptor coactivator AIB1 isoform AIB1-Delta3 on estrogenic ligands with different intrinsic activity.
    Reiter R; Oh AS; Wellstein A; Riegel AT
    Oncogene; 2004 Jan; 23(2):403-9. PubMed ID: 14691461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of the AIB1 interactome in breast cancer reveals MTA2 as a repressive partner which silences E-Cadherin to promote EMT and associates with a pro-metastatic phenotype.
    Varešlija D; Ward E; Purcell SP; Cosgrove NS; Cocchiglia S; O'Halloran PJ; Charmsaz S; Bane FT; Brett FM; Farrell M; Cryan J; Beausang A; Hudson L; Turnbul AK; Dixon JM; Hill ADK; Priedigkeit N; Oesterreich S; Lee AV; Sims AH; Redmond AM; Carroll JS; Young LS
    Oncogene; 2021 Feb; 40(7):1318-1331. PubMed ID: 33420368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors alpha and beta by coactivators and corepressors.
    Klinge CM; Jernigan SC; Mattingly KA; Risinger KE; Zhang J
    J Mol Endocrinol; 2004 Oct; 33(2):387-410. PubMed ID: 15525597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the AIB1 oncogene through mammalian target of rapamycin inhibition in the mammary gland.
    Torres-Arzayus MI; Yuan J; DellaGatta JL; Lane H; Kung AL; Brown M
    Cancer Res; 2006 Dec; 66(23):11381-8. PubMed ID: 17145884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of AIB1 for tamoxifen resistance in estrogen receptor-positive breast cancer cells.
    Su Q; Hu S; Gao H; Ma R; Yang Q; Pan Z; Wang T; Li F
    Oncology; 2008; 75(3-4):159-68. PubMed ID: 18827493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of AIB1 expression in human breast cancer.
    Iwase H; Omoto Y; Toyama T; Yamashita H; Hara Y; Sugiura H; Zhang Z
    Breast Cancer Res Treat; 2003 Aug; 80(3):339-45. PubMed ID: 14503806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a novel molecular sensor for imaging estrogen receptor-coactivator protein-protein interactions.
    Lake MC; Nguyen QD; Ali S; Aboagye EO
    PLoS One; 2012; 7(8):e44160. PubMed ID: 22952913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.